ESR2 and acute myeloid leukemia: It has been reported that peripheral blood mononuclear cells (PBMCs) express both estrogen receptor subtypes in subjects with chronic lymphocytic leukemia (CLL) [83], whereas, for instance, in acute myeloid leukemia (AML), ERβ was found to be the most abundant subtype.